Abstract: The present invention provides compounds of the formula: wherein A, B, D1, X, Y, Z, G, R1, R2, and R3a are as described herein, pharmaceutically acceptable salts thereof, and methods of using these compounds and pharmaceutically acceptable salts thereof for treating patients for cancer.
| # | Name | Date |
|---|---|---|
| 1 | 202417069852-STATEMENT OF UNDERTAKING (FORM 3) [16-09-2024(online)].pdf | 2024-09-16 |
| 2 | 202417069852-REQUEST FOR EXAMINATION (FORM-18) [16-09-2024(online)].pdf | 2024-09-16 |
| 3 | 202417069852-PRIORITY DOCUMENTS [16-09-2024(online)].pdf | 2024-09-16 |
| 4 | 202417069852-POWER OF AUTHORITY [16-09-2024(online)].pdf | 2024-09-16 |
| 5 | 202417069852-NOTIFICATION OF INT. APPLN. NO. & FILING DATE (PCT-RO-105-PCT Pamphlet) [16-09-2024(online)].pdf | 2024-09-16 |
| 6 | 202417069852-FORM 18 [16-09-2024(online)].pdf | 2024-09-16 |
| 7 | 202417069852-FORM 1 [16-09-2024(online)].pdf | 2024-09-16 |
| 8 | 202417069852-DECLARATION OF INVENTORSHIP (FORM 5) [16-09-2024(online)].pdf | 2024-09-16 |
| 9 | 202417069852-COMPLETE SPECIFICATION [16-09-2024(online)].pdf | 2024-09-16 |
| 10 | 202417069852-CLAIMS UNDER RULE 1 (PROVISIO) OF RULE 20 [16-09-2024(online)].pdf | 2024-09-16 |
| 11 | 202417069852-FORM 3 [16-01-2025(online)].pdf | 2025-01-16 |
| 12 | 202417069852-Proof of Right [10-03-2025(online)].pdf | 2025-03-10 |